# AbbVie Inc. (ABBV) — Q1-2024 Earnings Results

**Report date:** 2024-04-26 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2024

## Post-Earnings Brief

### Headline

AbbVie Misses on EPS, Stock Down 4.58%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.31 | N/A | -1.58% |

### Management Commentary

**Tone:** Defensive

Management expressed concerns about current market conditions impacting performance. They highlighted the importance of cost management while focusing on future growth opportunities.

**Key quotes:**

> Management noted ongoing challenges in the market.

> They emphasized a focus on cost management and efficiency.

> Future growth will depend on pipeline developments.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

AbbVie's earnings report shows a slight miss on EPS, which contributed to a significant drop in stock price by 4.58%. The lack of revenue figures and forward guidance adds uncertainty for investors. Management's defensive tone suggests they are cautious about upcoming challenges, which could impact investor sentiment moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2024_